Found: 32
Select item for more details and to access through your institution.
Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 23, p. 3779, doi. 10.3390/cells11233779
- By:
- Publication type:
- Article
lnsight into Metabolic <sup>1</sup>H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.
- Published in:
- Frontiers in Neurology, 2017, p. 1, doi. 10.3389/fneur.2017.00454
- By:
- Publication type:
- Article
Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 41, doi. 10.1177/1352458514540843
- By:
- Publication type:
- Article
Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00829
- By:
- Publication type:
- Article
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 108, doi. 10.1186/1750-1326-9-49
- By:
- Publication type:
- Article
Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.
- Published in:
- Journal of Neural Transmission, 2015, v. 122, n. 6, p. 825, doi. 10.1007/s00702-014-1335-7
- By:
- Publication type:
- Article
Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Germany-wide evaluation of residency in neurological intensive care medicine.
- Published in:
- BMC Medical Education, 2022, p. 1, doi. 10.1186/s12909-022-03441-4
- By:
- Publication type:
- Article
Peripheral CD19<sup>+</sup> B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 1, p. 57, doi. 10.1007/s00415-018-9092-4
- By:
- Publication type:
- Article
Diagnostic Value of the Impairment of Olfaction in Parkinson's Disease
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064735
- By:
- Publication type:
- Article
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016172
- By:
- Publication type:
- Article
Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221109750
- By:
- Publication type:
- Article
Atypical Occipital Calcinosis in a Caucasian Individual with Probable Diffuse Neurofibrillary Tangles with Calcification.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption.
- Published in:
- Blood Purification, 2021, v. 50, n. 1, p. 137, doi. 10.1159/000510292
- By:
- Publication type:
- Article
Laquinimod treatment in the R6/2 mouse model.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-04990-1
- By:
- Publication type:
- Article
Deep Brain Stimulation Improves Performance of Complex Instrumental Paradigms.
- Published in:
- European Neurology, 2008, v. 60, n. 1, p. 32, doi. 10.1159/000127977
- By:
- Publication type:
- Article
Positive effect of immunomodulatory therapies on disease progression in Huntington’s disease? Data from a real-world cohort.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221109750
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211035543
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211035543
- By:
- Publication type:
- Article
Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774973
- By:
- Publication type:
- Article
Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 10, p. 339, doi. 10.1177/1756285617721093
- By:
- Publication type:
- Article
Two years’ long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 2, p. 91, doi. 10.1177/1756285616679369
- By:
- Publication type:
- Article
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2015, v. 8, n. 5, p. 233, doi. 10.1177/1756285615594575
- By:
- Publication type:
- Article
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 5, p. 232, doi. 10.1177/1756285614544466
- By:
- Publication type:
- Article
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 6, p. 289, doi. 10.1177/1756285614556287
- By:
- Publication type:
- Article
Metabolic profiles by <sup>1</sup>H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176415
- By:
- Publication type:
- Article
Oral available agents in the treatment of RRMS: Authors' reply.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
- Published in:
- Drug, Healthcare & Patient Safety, 2013, v. 5, p. 37, doi. 10.2147/DHPS.S28822
- By:
- Publication type:
- Article
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
- Published in:
- Brain: A Journal of Neurology, 2011, v. 134, n. 3, p. 678, doi. 10.1093/brain/awq386
- By:
- Publication type:
- Article
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 7, p. 756, doi. 10.1001/jamaneurol.2015.0533
- By:
- Publication type:
- Article
Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence of Parkinson's disease in Germany based on prevalence data from 70 million patients of the statutory health insurance.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03739-4
- By:
- Publication type:
- Article